The global Veterinary Medication market size was valued at USD 24200 million in 2023 and is forecast to a readjusted size of USD 33780 million by 2030 with a CAGR of 4.9% during review period.
Veterinary medicine听is the branch of听medicine听that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human听animals. The scope of veterinary medicine is wide, covering all animal species, both听domesticated听and听wild, with a wide range of conditions which can affect different species.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
This report includes an overview of the development of the Veterinary Medication industry chain, the market status of Companion Animals (Oral, Injection), Livestock Animals (Oral, Injection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Veterinary Medication.
Regionally, the report analyzes the Veterinary Medication markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Veterinary Medication market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Veterinary Medication market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Veterinary Medication industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Injection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Veterinary Medication market.
Regional Analysis: The report involves examining the Veterinary Medication market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Veterinary Medication market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Veterinary Medication:
Company Analysis: Report covers individual Veterinary Medication players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Veterinary Medication This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Companion Animals, Livestock Animals).
Technology Analysis: Report covers specific technologies relevant to Veterinary Medication. It assesses the current state, advancements, and potential future developments in Veterinary Medication areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Veterinary Medication market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Veterinary Medication market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Oral
Injection
Other
麻豆原创 segment by Application
Companion Animals
Livestock Animals
麻豆原创 segment by players, this report covers
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Veterinary Medication product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Veterinary Medication, with revenue, gross margin and global market share of Veterinary Medication from 2019 to 2024.
Chapter 3, the Veterinary Medication competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Veterinary Medication market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Medication.
Chapter 13, to describe Veterinary Medication research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Veterinary Medication
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Veterinary Medication by Type
1.3.1 Overview: Global Veterinary Medication 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Veterinary Medication Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Oral
1.3.4 Injection
1.3.5 Other
1.4 Global Veterinary Medication 麻豆原创 by Application
1.4.1 Overview: Global Veterinary Medication 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Companion Animals
1.4.3 Livestock Animals
1.5 Global Veterinary Medication 麻豆原创 Size & Forecast
1.6 Global Veterinary Medication 麻豆原创 Size and Forecast by Region
1.6.1 Global Veterinary Medication 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Veterinary Medication 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Veterinary Medication 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Veterinary Medication 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Veterinary Medication 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Veterinary Medication 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Veterinary Medication 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Veterinary Medication Product and Solutions
2.1.4 Boehringer Ingelheim Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Veterinary Medication Product and Solutions
2.2.4 Zoetis Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Zoetis Recent Developments and Future Plans
2.3 Elanco Animal Health
2.3.1 Elanco Animal Health Details
2.3.2 Elanco Animal Health Major Business
2.3.3 Elanco Animal Health Veterinary Medication Product and Solutions
2.3.4 Elanco Animal Health Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Elanco Animal Health Recent Developments and Future Plans
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business
2.4.3 Merck Animal Health Veterinary Medication Product and Solutions
2.4.4 Merck Animal Health Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Merck Animal Health Recent Developments and Future Plans
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Veterinary Medication Product and Solutions
2.5.4 Virbac Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Virbac Recent Developments and Future Plans
2.6 Dechra Veterinary Products
2.6.1 Dechra Veterinary Products Details
2.6.2 Dechra Veterinary Products Major Business
2.6.3 Dechra Veterinary Products Veterinary Medication Product and Solutions
2.6.4 Dechra Veterinary Products Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Dechra Veterinary Products Recent Developments and Future Plans
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Veterinary Medication Product and Solutions
2.7.4 Ceva Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Ceva Recent Developments and Future Plans
2.8 Vetoquinol
2.8.1 Vetoquinol Details
2.8.2 Vetoquinol Major Business
2.8.3 Vetoquinol Veterinary Medication Product and Solutions
2.8.4 Vetoquinol Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Vetoquinol Recent Developments and Future Plans
2.9 Meiji
2.9.1 Meiji Details
2.9.2 Meiji Major Business
2.9.3 Meiji Veterinary Medication Product and Solutions
2.9.4 Meiji Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Meiji Recent Developments and Future Plans
2.10 Ouro Fino Saude
2.10.1 Ouro Fino Saude Details
2.10.2 Ouro Fino Saude Major Business
2.10.3 Ouro Fino Saude Veterinary Medication Product and Solutions
2.10.4 Ouro Fino Saude Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Ouro Fino Saude Recent Developments and Future Plans
2.11 Animalcare Group
2.11.1 Animalcare Group Details
2.11.2 Animalcare Group Major Business
2.11.3 Animalcare Group Veterinary Medication Product and Solutions
2.11.4 Animalcare Group Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Animalcare Group Recent Developments and Future Plans
2.12 Parnell
2.12.1 Parnell Details
2.12.2 Parnell Major Business
2.12.3 Parnell Veterinary Medication Product and Solutions
2.12.4 Parnell Veterinary Medication Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Parnell Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Veterinary Medication Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Veterinary Medication by Company Revenue
3.2.2 Top 3 Veterinary Medication Players 麻豆原创 Share in 2023
3.2.3 Top 6 Veterinary Medication Players 麻豆原创 Share in 2023
3.3 Veterinary Medication 麻豆原创: Overall Company Footprint Analysis
3.3.1 Veterinary Medication 麻豆原创: Region Footprint
3.3.2 Veterinary Medication 麻豆原创: Company Product Type Footprint
3.3.3 Veterinary Medication 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Veterinary Medication Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Veterinary Medication 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Veterinary Medication Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Veterinary Medication 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Veterinary Medication Consumption Value by Type (2019-2030)
6.2 North America Veterinary Medication Consumption Value by Application (2019-2030)
6.3 North America Veterinary Medication 麻豆原创 Size by Country
6.3.1 North America Veterinary Medication Consumption Value by Country (2019-2030)
6.3.2 United States Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Veterinary Medication Consumption Value by Type (2019-2030)
7.2 Europe Veterinary Medication Consumption Value by Application (2019-2030)
7.3 Europe Veterinary Medication 麻豆原创 Size by Country
7.3.1 Europe Veterinary Medication Consumption Value by Country (2019-2030)
7.3.2 Germany Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Medication Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Veterinary Medication Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Veterinary Medication 麻豆原创 Size by Region
8.3.1 Asia-Pacific Veterinary Medication Consumption Value by Region (2019-2030)
8.3.2 China Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Veterinary Medication Consumption Value by Type (2019-2030)
9.2 South America Veterinary Medication Consumption Value by Application (2019-2030)
9.3 South America Veterinary Medication 麻豆原创 Size by Country
9.3.1 South America Veterinary Medication Consumption Value by Country (2019-2030)
9.3.2 Brazil Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Medication Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Veterinary Medication Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Veterinary Medication 麻豆原创 Size by Country
10.3.1 Middle East & Africa Veterinary Medication Consumption Value by Country (2019-2030)
10.3.2 Turkey Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Veterinary Medication 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Veterinary Medication 麻豆原创 Drivers
11.2 Veterinary Medication 麻豆原创 Restraints
11.3 Veterinary Medication Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Veterinary Medication Industry Chain
12.2 Veterinary Medication Upstream Analysis
12.3 Veterinary Medication Midstream Analysis
12.4 Veterinary Medication Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
听
听
*If Applicable.
